Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C79794
http://purl.obolibrary.org/obo/NCIT_C79794
|
|---|---|
| Preferred Name | VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593 |
| Definitions |
An oral formulation containing a small-molecule receptor tyrosine kinase inhibitor of both vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) with potential antineoplastic activity. TAK-593 selectively binds to and inhibits VEGFR and PDGFR, which may result in the inhibition of angiogenesis and tumor cell proliferation.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | An oral formulation containing a small-molecule receptor tyrosine kinase inhibitor of both vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) with potential antineoplastic activity. TAK-593 selectively binds to and inhibits VEGFR and PDGFR, which may result in the inhibition of angiogenesis and tumor cell proliferation. |
|---|---|
| prefLabel | VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593
|
| label | VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593
|
| PDQ_Closed_Trial_Search_ID | 618858
|
| code | C79794
|
| Has_Target | |
| prefixIRI | NCIT:C79794
|
| in_subset |
See more
See less
|
| Display_Name | VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593
|
| Preferred_Name | VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593
|
| FDA_UNII_Code | H3I42X8XX7
|
| Contributing_Source |
CTRP
FDA
|
| Maps_To | VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593
|
| CAS_Registry | 1005780-62-0
|
| NCI_Drug_Dictionary_ID | 618858
|
| Legacy Concept Name | VEGFR_PDGFR_Tyrosine_Kinase_Inhibitor_TAK-593
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 618858
|
| Semantic_Type | Pharmacologic Substance
|
| UMLS_CUI | C2703162
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |